Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have undergone cardiac (heart) surgery
- People (or their next of kin) who have signed a consent form to take part
- People who develop a new irregular heart rhythm called atrial fibrillation (a condition where the upper chambers of the heart beat irregularly) for the first time within the first seven days after their cardiac surgery, while still in the hospital ward, intermediate care unit, or intensive care unit
Who may not be able to join:
- People who have previously had a procedure to treat abnormal electrical signals in the left side of the heart (left atrial ablation)
- People who have a history of a stroke caused by a blood clot travelling from the heart
- People who have taken the heart medication amiodarone within the past three months
- People who have ever been diagnosed with an irregular heart rhythm called atrial fibrillation or atrial flutter before their surgery
- People whose heart pumping function is significantly reduced (confirm with trial site)
- People who are already taking part in another study that involves radiation exposure
- People who required mechanical devices to help support their heart's pumping function during or around the time of surgery (such as a balloon pump or a heart-lung bypass machine)
- People whose heart rate is 50 beats per minute or above AND who cannot safely receive a medication called adenosine
- People who are allergic or intolerant to adenosine
- People who have a severe form of chronic lung disease (COPD, classed as Gold Stage IV)
- People who have a history of asthma
- People who have a history of a heart condition called Long-QT syndrome (a condition affecting the heart's electrical rhythm)
- People who are medically unstable at the time of assessment, as determined by the treating doctor
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David Santer, Dr. med., Department of Cardiac Surgery, University Hospital Basel
Phone: +41 61 32 85818
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
localisation of foci and rotors maintaining NOAF after cardiac surgery identified by mapping
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.